-
公开(公告)号：US12264328B2
公开(公告)日：2025-04-01
申请号：US18481393
申请日：2023-10-05
Applicant: ReNAgade Therapeutics Management Inc.
Inventor： Giedrius Gasiunas , Alim Ladha , Vladimir Presnyak , Muthusamy Jayaraman , Elisabeth Narayanan
Abstract: The present disclosure provides methods and compositions comprising Cas TypeV programmable nucleases and lipid nanoparticles capable of delivering the Cas TypeV programmable nucleases and genome editing systems comprising same.
Search Results
1
records
(took 0.011 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
